These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3291898)

  • 1. The mineralocorticoid hormones in human hypertension. Remarks after receiving the Robert Tigerstedt award.
    Biglieri EG
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):313-8. PubMed ID: 3291898
    [No Abstract]   [Full Text] [Related]  

  • 2. Liquorice: new insights into mineralocorticoid and glucocorticoid hypertension.
    Morris DJ
    R I Med; 1993 May; 76(5):251-4. PubMed ID: 8518501
    [No Abstract]   [Full Text] [Related]  

  • 3. Are the hypokalaemia and hypertension in Cushing's disease caused by apparent mineralocorticoid excess?
    Hermus A; Hobma S; Pieters G; van de Calseyde J; Smals A; Kloppenborg P
    Horm Metab Res; 1991 Nov; 23(11):572-3. PubMed ID: 1816069
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiovascular action of steroid hormones].
    Sato A; Nishimoto M
    Nihon Naika Gakkai Zasshi; 2006 Apr; 95(4):709-15. PubMed ID: 16722441
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension.
    New MI; Levine LS; Biglieri EG; Pareira J; Ulick S
    J Clin Endocrinol Metab; 1977 May; 44(5):924-33. PubMed ID: 870517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent mineralocorticoid excess.
    Funder JW
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):613-21. PubMed ID: 8575412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the role of the central nervous system in mineralocorticoid hypertension?
    Gómez Sánchez EP
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):374-81. PubMed ID: 1647798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoids and hypertension.
    Holland OB; Gomez-Sanchez C
    Am J Nephrol; 1983; 3(2-3):156-63. PubMed ID: 6346874
    [No Abstract]   [Full Text] [Related]  

  • 9. Mineralocorticoid-stimulating activity of adipose tissue.
    Lamounier-Zepter V; Ehrhart-Bornstein M; Bornstein SR
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):567-75. PubMed ID: 16311217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid mechanisms.
    Walker BR
    Horm Res; 2003; 59 Suppl 1():55. PubMed ID: 12566721
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings of the symposium Mineralocorticoids in Essential and Secondary Hypertension. Newport Beach, California, February 28, 1982.
    Clin Exp Hypertens A; 1982; 4(9-10):1447-934. PubMed ID: 7139969
    [No Abstract]   [Full Text] [Related]  

  • 12. On the pleotropic actions of mineralocorticoids.
    Lang F
    Nephron Physiol; 2014; 128(1-2):1-7. PubMed ID: 25376771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of action of mineralocorticoid hormones.
    Rossier BC
    Endocr Res; 1989; 15(1-2):203-26. PubMed ID: 2667967
    [No Abstract]   [Full Text] [Related]  

  • 14. Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome.
    Ulick S; Wang JZ; Blumenfeld JD; Pickering TG
    J Clin Endocrinol Metab; 1992 May; 74(5):963-7. PubMed ID: 1569172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mineralocorticoid hypertension: clinical and laboratory aspects with emphasis on selective percutaneous venography associated with aldosterone determination in the adrenal vein].
    Wajchenberg BL; Liberman B; Novaes M; Tambascia M; Lima S; Sabagga E; Okada H; Pieroni RR; de Faria CV; Bloise W; Mattar E
    AMB Rev Assoc Med Bras; 1977 May; 23(5):144-8. PubMed ID: 302962
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypertension and steroid hormones].
    Miyamori I
    Nihon Rinsho; 1997 Aug; 55(8):1977-81. PubMed ID: 9284410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
    Fardella CE; Montero J; Mosso L
    Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular remodeling and mineralocorticoids.
    Weber KT; Sun Y; Campbell SE; Slight SH; Ganjam VK
    J Endocrinol Invest; 1995; 18(7):533-9. PubMed ID: 9221271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are there unknown mineralocorticoids in low-renin essential hypertension?
    Hollifield JW; Slaton PE; Wilson HM; Sennett JA; Yarbro L; Island DP; Liddle GW
    Mayo Clin Proc; 1977 May; 52(5):329-33. PubMed ID: 323587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Steroid hormone].
    Miyamori I; Hatakeyama H; Inaba S
    Nihon Rinsho; 2000 Jan; 58 Suppl 1():487-91. PubMed ID: 11026317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.